. Nonclinical Safety Assessment of the γ-Secretase Inhibitor Avagacestat. Toxicol Sci. 2018 Jun 1;163(2):525-542. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Avagacestat